C. Ansquer
-
- Radiopharmaceutical Chemistry and Applications 14
-
- Thyroid Cancer Diagnosis and Treatment 9
- Nephrology top 5%
- Parathyroid Disorders and Treatments 9
-
- Cancer, Hypoxia, and Metabolism 7
-
- Lung Cancer Research Studies 9
-
- Neuroendocrine Tumor Research Advances 23
-
- Neuroblastoma Research and Treatments 13
-
- Adrenal and Paraganglionic Tumors 8
- Co-authors
- Françoise Kraeber‐BodéréÉric MiralliéCaroline Bodet‐MilinThomas CarlierCaroline RousseauD. DruiClément BaillyJacques Barbet
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (7 papers)Cancers (3 papers)Journal of Nuclear Medicine (3 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
C. Ansquer
54 papers receiving 929 citations
Peers
Comparison fields: 5 of 55
- Radiology, Nuclear Medicine and Imaging 383
- Endocrinology, Diabetes and Metabolism 256
- Nephrology 109
- Cancer Research 132
- Oncology 229
Countries citing papers authored by C. Ansquer
This map shows the geographic impact of C. Ansquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ansquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ansquer more than expected).
Fields of papers citing papers by C. Ansquer
This network shows the impact of papers produced by C. Ansquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ansquer. The network helps show where C. Ansquer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Ansquer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 15 | |
| 11 | 2017 | 1 | |
| 12 | 2015 | 12 | |
| 13 | 2015 | 6 | |
| 14 | 2012 | 44 | |
| 15 | 2012 | 9 | |
| 16 | 2010 | 27 | |
| 17 | 2009 | 19 | |
| 18 | 2007 | 54 | |
| 19 | 2007 | 31 | |
| 20 | Technical feasibility of pinhole SPECT acquisition in primary hyperparathyroidism: phantom and patient studies. | 2006 | 1 |
About C. Ansquer
C. Ansquer is a scholar working on Nephrology, Neurology, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 59 papers that have together received 943 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (23 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Neuroblastoma Research and Treatments (13 papers), Parathyroid Disorders and Treatments (9 papers), Lung Cancer Research Studies (9 papers), Thyroid Cancer Diagnosis and Treatment (9 papers), Adrenal and Paraganglionic Tumors (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (383 citations), Endocrinology, Diabetes and Metabolism (256 citations), Nephrology (109 citations), Cancer Research (132 citations) and Oncology (229 citations). C. Ansquer has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Françoise Kraeber‐Bodéré, Éric Mirallié, Caroline Bodet‐Milin, Thomas Carlier, Caroline Rousseau, D. Drui, Clément Bailly, Jacques Barbet, David Taïeb and Christophe Leux. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Cancers, Journal of Nuclear Medicine, Surgery and Langenbeck s Archives of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.